doi: 10.1016/S1743-9191(06)60056-3.
A review of the epidemiology, pathogenesis and management of tetanus
Affiliations
- PMID: 17462232
- DOI: 10.1016/S1743-9191(06)60056-3
Item in Clipboard
A review of the epidemiology, pathogenesis and management of tetanus
Int J Surg.
2004.
Free article
Abstract
Tetanus remains an important disease worldwide. In the United Kingdom, the elderly and intravenous drug users are at particular risk of acquiring clinical tetanus. Tetanus is associated with a high morbidity and mortality. Once the diagnosis of tetanus is suspected, intensive management is necessary. In this article we review the history, epidemiology, microbiology, clinical features, mode of transmission, pathogenesis, differential diagnosis, management, complications and prevention of this life threatening disease.
Similar articles
-
Tetanus in developing countries: a case series and review.Can J Anaesth. 2009 Apr;56(4):307-15. doi: 10.1007/s12630-009-9058-1. Epub 2009 Feb 14. Can J Anaesth. 2009. PMID: 19296192 Review.
-
Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.Ann Med. 2008;40(2):129-38. doi: 10.1080/07853890701753664. Ann Med. 2008. PMID: 18293143 Review.
-
Colonic diverticular disease: current perspectives.JNMA J Nepal Med Assoc. 2007 Oct-Dec;46(168):206-13. JNMA J Nepal Med Assoc. 2007. PMID: 18340365 Review.
-
Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management.J Am Acad Dermatol. 2007 Nov;57(5):737-63; quiz 764-6. doi: 10.1016/j.jaad.2007.06.027. J Am Acad Dermatol. 2007. PMID: 17939933 Review.
-
Burn prevention mechanisms and outcomes: pitfalls, failures and successes.Burns. 2009 Mar;35(2):181-93. doi: 10.1016/j.burns.2008.06.002. Epub 2008 Oct 15. Burns. 2009. PMID: 18926639 Review.
Cited by
-
Safety of equine tetanus antitoxin for prophylactic use in Ethiopia: a retrospective multi-center study.Trop Med Health. 2023 May 5;51(1):23. doi: 10.1186/s41182-023-00518-8. Trop Med Health. 2023. PMID: 37147727 Free PMC article.
-
Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019.Front Public Health. 2022 Nov 29;10:952161. doi: 10.3389/fpubh.2022.952161. eCollection 2022. Front Public Health. 2022. PMID: 36523572 Free PMC article.
-
Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines.Pharmaceutics. 2022 Sep 20;14(10):1985. doi: 10.3390/pharmaceutics14101985. Pharmaceutics. 2022. PMID: 36297421 Free PMC article.
-
An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo.Toxicon X. 2019 Jan 18;2:100006. doi: 10.1016/j.toxcx.2019.100006. eCollection 2019 Apr. Toxicon X. 2019. PMID: 32550563 Free PMC article.
-
The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.Biomed Res Int. 2018 Dec 31;2018:6057348. doi: 10.1155/2018/6057348. eCollection 2018. Biomed Res Int. 2018. PMID: 30687751 Free PMC article.
LinkOut - more resources
Full Text Sources
